Kurter, H. Et Al. 2022. In-silico drug-likeness analysis, ADME properties, and molecular docking studies of cyanidin-3-arabinoside, pelargonidin-3-glucoside, and peonidin-3-arabinoside as natural anticancer compounds against acting receptor-like kinase 5 receptor.. ANTI-CANCER DRUGS , vol.33, no.6 , 517-522.

Kurter, H., Mert-Ozupek, N., Ellidokuz, H., & Calibasi-Kocal, G., (2022). In-silico drug-likeness analysis, ADME properties, and molecular docking studies of cyanidin-3-arabinoside, pelargonidin-3-glucoside, and peonidin-3-arabinoside as natural anticancer compounds against acting receptor-like kinase 5 receptor.. ANTI-CANCER DRUGS , vol.33, no.6, 517-522.

Kurter, Hasan Et Al. "In-silico drug-likeness analysis, ADME properties, and molecular docking studies of cyanidin-3-arabinoside, pelargonidin-3-glucoside, and peonidin-3-arabinoside as natural anticancer compounds against acting receptor-like kinase 5 receptor.," ANTI-CANCER DRUGS , vol.33, no.6, 517-522, 2022

Kurter, Hasan Et Al. "In-silico drug-likeness analysis, ADME properties, and molecular docking studies of cyanidin-3-arabinoside, pelargonidin-3-glucoside, and peonidin-3-arabinoside as natural anticancer compounds against acting receptor-like kinase 5 receptor.." ANTI-CANCER DRUGS , vol.33, no.6, pp.517-522, 2022

Kurter, H. Et Al. (2022) . "In-silico drug-likeness analysis, ADME properties, and molecular docking studies of cyanidin-3-arabinoside, pelargonidin-3-glucoside, and peonidin-3-arabinoside as natural anticancer compounds against acting receptor-like kinase 5 receptor.." ANTI-CANCER DRUGS , vol.33, no.6, pp.517-522.

@article{article, author={Hasan Kurter Et Al. }, title={In-silico drug-likeness analysis, ADME properties, and molecular docking studies of cyanidin-3-arabinoside, pelargonidin-3-glucoside, and peonidin-3-arabinoside as natural anticancer compounds against acting receptor-like kinase 5 receptor.}, journal={ANTI-CANCER DRUGS}, year=2022, pages={517-522} }